Search Within

Center for Hematologic Malignancies

Formats
  1. Journal Article (6195)
  2. Meeting Abstract (6166)
  3. Review (401)
  4. Book Section (216)
  5. Editorial (172)
  6. Research Letter (160)
  7. Guidelines (83)
  8. Conference Paper (70)
  9. Correspondence (61)
  10. Miscellaneous (19)
  11. Book Whole (10)
Groups
  1. Department of Medicine (11094)
  2. Hematologic Malignancies, Division of (10645)
  3. GSK Faculty (5449)
  4. Adult Leukemia (3723)
  5. Sloan Kettering Institute Faculty (3375)
  6. Hematologic Malignancies Research (3005)

More Groups

People
  1. Sergio Giralt (1069)
  2. Miguel-Angel Perales (946)
  3. Ross Levine (787)
  4. Andrew Zelenetz (785)
  5. Steven Horwitz (671)
  6. Martin Tallman (655)

More People

Years
  1. 2025 (317)
  2. 2024 (704)
  3. 2023 (877)
  4. 2022 (830)
  5. 2021 (802)
  6. 2020 (874)

More Years

Publications
  1. Blood (3413)
  2. Journal of Clinical Oncology (869)
  3. Biology of Blood and Marrow Transplantation (602)
  4. Clinical Lymphoma, Myeloma and Leukemia (304)
  5. Cancer Research (300)
  6. Haematologica (268)

More Publications

Publishers
  1. American Society of Hematology (3684)
  2. Elsevier Inc. (1669)
  3. Nature Publishing Group (1118)
  4. American Society of Clinical Oncology (918)
  5. American Association for Cancer Research (680)
  6. Wiley Blackwell (437)

More Publishers

Results (13553)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Small-molecule inhibitors of setd8 with cellular activity
    Journal Article

    Blum, G.; Ibáñez, G.; Rao, X.; Shum, D.; Radu, C.; Djaballah, H.; Rice, J. C.; Luo, M.
    ACS Chemical Biology (2014)

    Fulltext@MSK | Save
  • HSP90 supports tumor growth and angiogenesis through PRKD2 protein stabilization
    Journal Article

    Azoitei, N.; Diepold, K.; Brunner, C.; Rouhi, A.; Genze, F.; Becher, A.; Kestler, H.; Van Lint, J.; Chiosis, G.; Koren, J.; more...
    Cancer Research (2014)

    Fulltext@MSK | Save
  • Somatic alterations and dysregulation of epigenetic modifiers in cancers
    Journal Article

    Aumann, S.; Abdel-Wahab, O.
    Biochemical and Biophysical Research Communications (2014)

    Fulltext@MSK | Save
  • Blinatumomab in pediatric patients with relapsed/refractory (R/R) B-cell precursor acute lymphoblastic leukemia (Bcp-All): A phase 1/2 study
    Meeting Abstract

    Whitlock, J.; Von Stackelberg, A.; Handgretinger, R.; Locatelli, F.; Rizzari, C.; Trippett, T.; Borkhardt, A.; O'brien, M.; Rheingold, S.; Gore, L.
    Pediatric Blood and Cancer (2014)

    Fulltext@MSK | Save
  • Efficacy of idelalisib in CLL subpopulations harboring del(17p) and other adverse prognostic factors: Results from a phase 3, randomized, double-blind, placebo-controlled trial
    Meeting Abstract

    Stilgenbauer, S.; Hallek, M. J.; Coutre, S. E.; Furman, R. R.; Cheson, B. D.; Pagel, J. M.; Hillmen, P.; Barrientos, J. C.; Zelenetz, A. D.; Kipps, T. J.; more...
    Oncology Research and Treatment (2014)

    Fulltext@MSK | Save
  • Efficacy of idelalisib in Cll subpopulations harboring del(17p) and other adverse prognostic factors: Results from a phase 3, randomized, double-blind, placebo-controlled trial
    Meeting Abstract

    Stilgenbauer, S.; Coutre, S. E.; Furman, R. R.; Cheson, B. D.; Pagel, J. M.; Hillmen, P.; Barrientos, J. C.; Zelenetz, A. D.; Kipps, T. J.; Flinn, I. W.; more...
    Haematologica (2014)

    Fulltext@MSK | Save
  • Quizartinib (Ac220) in patients with flt3-Itd(+) relapsed or refractory acute myeloid leukemia: Final results of a randomized phase 2 study
    Meeting Abstract

    Russell, N.; Tallman, M. S.; Goldberg, S.; Perl, A. E.; Marie, J. P.; Martinelli, G.; Larson, R. A.; Schiller, G.; Trone, D.; Gammon, G.; more...
    Haematologica (2014)

    Fulltext@MSK | Save
  • Molecular predictors of response to decitabine in chronic myelomonocytic leukemia
    Meeting Abstract

    Rossi, A.; Valencia, A.; Abdel-Wahab, O.; Masala, E.; Buchi, F.; Sanna, A.; Bosi, A.; Levis, A.; Allione, B.; Lunghi, M.; more...
    Haematologica (2014)

    Fulltext@MSK | Save
  • Integrated genomic analysis illustrates the central role of jak-stat pathway activation in myeloproliferative neoplasm pathogenesis
    Meeting Abstract

    Rampal, R.; Al-Shahrour, F.; Abdel-Wahab, O.; Patel, J.; Brunel, J. P.; Mermel, C.; Bass, A.; Pretz, J.; Ahn, J.; Hricik, T.; more...
    Haematologica (2014)

    Fulltext@MSK | Save
  • Phase I trial of autologous Cd19-targeted car-modified T cells as consolidation after purine analog-based first-line therapy in patients with previously untreated cll
    Meeting Abstract

    Park, J. H.; Riviere, I.; Wang, X.; Bartido, S.; Sadelain, M.; Brentjens, R. J.
    Haematologica (2014)

    Fulltext@MSK | Save